[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia Pacific Tumor Ablation Market By Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation) By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer) By Country, Industry Analysis and Forecast, 2019 - 2025

February 2020 | 98 pages | ID: AC679B899E54EN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Asia Pacific Tumor Ablation Market would witness market growth of 13.1% CAGR during the forecast period (2019-2025).

Technological innovations to enhance accuracy, portability, and cost-effectiveness are factors that enable market players to continuously improve and launch advanced products. Image-guided equipment and cryoablation are notable examples of these new technologies. The use of cooled radiofrequency denervation technology with internally cooled radiofrequency probes to increase the size of the lesion is one of the new technologies that is expected to play an important role in the expansion of the sector. This procedure allows complete denervation of the sacroiliac joint, which assists in the treatment of pain.

The microwave ablation technology is expected to experience an exponential market growth during the forecast period. Unlike electrical current in a radiofrequency ablation device, the energy of the microwave (MW) ablation device propagates electromagnet effect. This improves the use of microwave ablation technology in fabrics with low electrical conductivity such as bones and lungs.

The major benefits of this technology are the increased volume of tumor ablation, high-temperature stability, low ablation discomfort, and optimal cystic mass heating. Such advantages are expected to support the growth of this segment. In addition, the minimum duration of the procedure (5-10 minutes), improved efficacy with minimal complications and minimized hospital stay are projected to drive segment development.

Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.

Scope of the Study

Market Segmentation:

By Treatment
  • Surgical Ablation
  • Laparoscopic Ablation and
  • Percutaneous Ablation
By Technology
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation and
  • Other Technology
By Application
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Kidney Cancer
  • Prostate Cancer and
  • Other Cancer
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia Pacific
Companies Profiled
  • Medtronic PLC
  • Johnson and Johnson (Ethicon, Inc.)
  • Boston Scientific Corporation
  • Misonix, Inc.
  • EDAP TMS S.A.
  • Theraclion SA
  • AngioDynamics, Inc.
  • Mermaid Medical A/S
  • HealthTronics, Inc. (Altaris Capital Partners, LLC)
  • SonaCare Medical, LLC
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Asia Pacific Tumor Ablation Market, by Treatment
  1.4.2 Asia Pacific Tumor Ablation Market, by Technology
  1.4.3 Asia Pacific Tumor Ablation Market, by Application
  1.4.4 Asia Pacific Tumor Ablation Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. COMPETITION ANALYSIS - GLOBAL

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
  3.2.1 Partnerships, Collaborations and Agreements
  3.2.2 Product Launches and Product Expansions
  3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
  3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
  3.3.2 Key Strategic Move: (Acquisition and Mergers: Jan 2016- Oct 2019) Leading Players

CHAPTER 4. ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT

4.1 Asia Pacific Surgical Ablation Market by Country
4.2 Asia Pacific Laparoscopic Ablation Market by Country
4.3 Asia Pacific Percutaneous Ablation Market by Country

CHAPTER 5. ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY

5.1 Asia Pacific Radiofrequency Ablation Market by Country
5.2 Asia Pacific Microwave Ablation Market by Country
5.3 Asia Pacific Cryoablation Market by Country
5.4 Asia Pacific Irreversible Electroporation Market by Country
5.5 Asia Pacific Other Technology Market by Country

CHAPTER 6. ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION

6.1 Asia Pacific Liver Cancer Market by Country
6.2 Asia Pacific Breast Cancer Market by Country
6.3 Asia Pacific Lung Cancer Market by Country
6.4 Asia Pacific Kidney Cancer Market by Country
6.5 Asia Pacific Prostate Cancer Market by Country
6.6 Asia Pacific Other Cancer Market by Country

CHAPTER 7. ASIA PACIFIC TUMOR ABLATION MARKET BY COUNTRY

7.1 China Tumor Ablation Market
  7.1.1 China Tumor Ablation Market by Treatment
  7.1.2 China Tumor Ablation Market by Technology
  7.1.3 China Tumor Ablation Market by Application
7.2 Japan Tumor Ablation Market
  7.2.1 Japan Tumor Ablation Market by Treatment
  7.2.2 Japan Tumor Ablation Market by Technology
  7.2.3 Japan Tumor Ablation Market by Application
7.3 India Tumor Ablation Market
  7.3.1 India Tumor Ablation Market by Treatment
  7.3.2 India Tumor Ablation Market by Technology
  7.3.3 India Tumor Ablation Market by Application
7.4 South Korea Tumor Ablation Market
  7.4.1 South Korea Tumor Ablation Market by Treatment
  7.4.2 South Korea Tumor Ablation Market by Technology
  7.4.3 South Korea Tumor Ablation Market by Application
7.5 Australia Tumor Ablation Market
  7.5.1 Australia Tumor Ablation Market by Treatment
  7.5.2 Australia Tumor Ablation Market by Technology
  7.5.3 Australia Tumor Ablation Market by Application
7.6 Singapore Tumor Ablation Market
  7.6.1 Singapore Tumor Ablation Market by Treatment
  7.6.2 Singapore Tumor Ablation Market by Technology
  7.6.3 Singapore Tumor Ablation Market by Application
7.7 Rest of Asia Pacific Tumor Ablation Market
  7.7.1 Rest of Asia Pacific Tumor Ablation Market by Treatment
  7.7.2 Rest of Asia Pacific Tumor Ablation Market by Technology
  7.7.3 Rest of Asia Pacific Tumor Ablation Market by Application

CHAPTER 8. COMPANY PROFILES

8.1 Medtronic PLC
  8.1.1 Company overview
  8.1.2 Financial Analysis
  8.1.3 Segmental and Regional Analysis
  8.1.4 Research & Development Expenses
  8.1.5 Recent strategies and developments:
    8.1.5.1 Acquisition and Mergers:
    8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
  8.2.1 Company Overview
  8.2.2 Financial Analysis
  8.2.3 Segmental &Regional Analysis
  8.2.4 Research & Development Expenses
  8.2.1 Recent strategies and developments:
    8.2.1.1 Acquisition and Mergers:
    8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
  8.3.1 Company Overview
  8.3.2 Financial Analysis
  8.3.3 Segmental and Regional Analysis
  8.3.4 Research & Development Expense
  8.3.5 Recent strategies and developments:
    8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
  8.4.1 Company Overview
  8.4.2 Financial Analysis
  8.4.3 Regional Analysis
  8.4.4 Research & Development Expense
  8.4.5 Recent strategies and developments:
    8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
  8.5.1 Company Overview
  8.5.2 Financial Analysis
  8.5.3 Segmental and Regional Analysis
  8.5.4 Research & Development Expense
  8.5.5 Recent strategies and developments:
    8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
  8.6.1 Company Overview
  8.6.2 Financial Analysis
  8.6.3 Recent strategies and developments:
    8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
  8.7.1 Company Overview
  8.7.2 Financial Analysis
  8.7.3 Regional Analysis
  8.7.4 Research & Development Expense
  8.7.5 Recent strategies and developments:
    8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
  8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
  8.9.1 Company Overview
  8.9.2 Recent strategies and developments:
    8.9.2.1 Acquisition and Mergers:
    8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
  8.10.1 Company overview

LIST OF TABLES

TABLE 1 ASIA PACIFIC TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 ASIA PACIFIC SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 ASIA PACIFIC SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 ASIA PACIFIC LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 ASIA PACIFIC LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 ASIA PACIFIC PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 ASIA PACIFIC PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 ASIA PACIFIC RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 ASIA PACIFIC RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 ASIA PACIFIC MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 19 ASIA PACIFIC MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 20 ASIA PACIFIC CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 ASIA PACIFIC CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 ASIA PACIFIC IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 ASIA PACIFIC IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 ASIA PACIFIC OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 ASIA PACIFIC LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 29 ASIA PACIFIC LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 30 ASIA PACIFIC BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 31 ASIA PACIFIC BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 32 ASIA PACIFIC LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 33 ASIA PACIFIC LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 34 ASIA PACIFIC KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 35 ASIA PACIFIC KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 36 ASIA PACIFIC PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 37 ASIA PACIFIC PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 38 ASIA PACIFIC OTHER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 39 ASIA PACIFIC OTHER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 40 ASIA PACIFIC TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 41 ASIA PACIFIC TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 42 CHINA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 CHINA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 CHINA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 CHINA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 CHINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 47 CHINA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 48 CHINA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 49 CHINA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 50 JAPAN TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 51 JAPAN TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 52 JAPAN TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 53 JAPAN TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 54 JAPAN TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 55 JAPAN TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 56 JAPAN TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 57 JAPAN TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 58 INDIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 59 INDIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 60 INDIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 61 INDIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 62 INDIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 63 INDIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 64 INDIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 INDIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 SOUTH KOREA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 67 SOUTH KOREA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 68 SOUTH KOREA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 69 SOUTH KOREA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 70 SOUTH KOREA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 71 SOUTH KOREA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 72 SOUTH KOREA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 73 SOUTH KOREA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 74 AUSTRALIA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 75 AUSTRALIA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 76 AUSTRALIA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 77 AUSTRALIA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 78 AUSTRALIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 79 AUSTRALIA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 80 AUSTRALIA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 81 AUSTRALIA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 82 SINGAPORE TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 83 SINGAPORE TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 84 SINGAPORE TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 85 SINGAPORE TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 86 SINGAPORE TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 87 SINGAPORE TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 88 SINGAPORE TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 89 SINGAPORE TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 90 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 91 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 92 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 93 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 94 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 95 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 96 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 97 REST OF ASIA PACIFIC TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 98 KEY INFORMATION – MEDTRONIC PLC
TABLE 99 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 100 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 101 KEY INFORMATION – MISONIX, INC.
TABLE 102 KEY INFORMATION – EDAP TMS S.A.
TABLE 103 KEY INFORMATION – THERACLION SA
TABLE 104 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 105 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 106 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 107 KEY INFORMATION – SONACARE MEDICAL, LLC

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: JAN 2016 – OCT 2019) LEADING PLAYERS


More Publications